Unlocking the Therapeutic Potential of Patchouli Leaves: A Comprehensive Review of Phytochemical and Pharmacological Insights
Plants,
Journal Year:
2025,
Volume and Issue:
14(7), P. 1034 - 1034
Published: March 26, 2025
Plant-based
products
play
an
increasingly
vital
role
in
the
pharmaceutical
industry,
including
Pogostemon
cablin
(Blanco)
Benth.
(patchouli),
which
is
notable
for
its
rich
history
and
extensive
use
traditional
medicine.
Patchouli
has
a
longstanding
historical
as
remedy
wide
range
of
health
conditions,
colds,
fevers,
headaches,
inflammation,
digestive
disorders,
insect
snake
bites.
Comprehensive
phytochemical
studies
have
revealed
that
patchouli
leaves
contain
diverse
valuable
bioactive
compounds,
notably
alcohol,
β-patchoulene,
pogostone,
α-bulnesene,
β-caryophyllene.
Recent
demonstrated
exhibit
various
pharmacological
properties,
anti-oxidant,
anti-inflammatory,
antimicrobial,
antidepressant,
anticancer
effects.
Despite
robust
knowledge,
specific
therapeutic
applications
require
scientific
validation
standardization
their
compounds.
This
review
provides
comprehensive
overview
existing
literature
on
composition,
underlying
mechanisms
action
essential
oil
(PEO)
plant
extracts
obtained
from
leaves.
It
offers
detailed
insights
into
potential
applications,
aiming
to
inform
guide
future
research
across
multiple
medical
disciplines.
Ultimately,
this
underscores
need
further
validate
develop
medicinal
leaves,
providing
foundation
healthcare
advancements.
Language: Английский
Effects of five cannabis oils with different CBD:THC ratios and terpenes on hypertension, dyslipidemia, hepatic steatosis, oxidative stress, and CB1 receptor in an experimental model
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 22, 2025
Abstract
Background:
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
a
common
disorder
caused
by
oxidative
stress
and
dysregulation
of
lipid
metabolism.
The
endocannabinoid
system
(ECS),
particularly
the
type
1
cannabinoid
(CB1)
receptor,
plays
crucial
role
in
NAFLD
progression.
Cannabinoids,
such
as
cannabidiol
(CBD)
tetrahydrocannabinol
(THC),
along
with
terpenes,
beta-myrcene
d-limonene,
have
shown
potential
therapeutic
effects
on
health,
reducing
modulating
This
study
aimed
to
analyse
five
cannabis
oils
(COs),
each
different
CBD:THC
ratios
terpenes
content,
hypertension,
dyslipidemia,
hepatic
steatosis,
stress,
CB1
receptor
expression
an
experimental
model
induced
sucrose-rich
diet
(SRD)
Wistar
rats
for
3
weeks.
Methods:
Male
were
fed
either
a:
1)
reference
(RD;
standard
commercial
laboratory
diet)
or
2)
7
SRD+CO
following:
3)
SRD+THC;
4)
SRD+CBD;
5)
SRD+CBD:THC
1:1;
6)
2:1;
7)
3:1.
COs
administered
orally
at
dose
1.5
mg
total
cannabinoids/kg
body
weight
daily.
content
all
used
was
determined.
found
beta-myrcene,
terpinolene,
linalool,
beta-caryophyllene,
alpha-humulene,
(-)-guaiol,
(-)-alpha-bisabolol.
During
period,
weight,
food
intake
blood
pressure
measured.
Serum
glucose,
triglyceride,
cholesterol,
uric
acid,
alanine
aminotransferase
(ALT),
aspartate
(AST),
alkaline
phosphatase
(AP)
levels
evaluated.
Liver
tissue
histology,
activity
score
(NAS),
triglyceride
cholesterol
lipogenic
enzyme
activities,
related
mitochondrial
acid
oxidation,
reactive
oxygen
species
(ROS),
thiobarbituric
substance
(TBARS),
antioxidant
activities
also
Results:
The
results
showed
that
SRD-fed
developed
damage,
peroxidation,
stress.
accompanied
upregulation
expression.
CBD-rich
CO,
1:1
ratio
CO;
2:1
CO
3:1
antihypertensive
properties.
THC-rich
greatest
beneficial
against
steatosis
damage.
All
exhibited
tissue.
associated
normal
Conclusions:
This
demonstrated
COs,
can
effectively
reduce
damage
SRD-induced
NAFLD.
higher
proportion
CBD
their
composition
These
findings
suggest
especially
those
may
represent
promising
approach
managing
preventing
its
progression
more
severe
disease.
Language: Английский